Onconetix vs YD Bio
ONCO and YDES side by side. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How ONCO and YDES compare
YD Bio grew revenue faster over the last twelve months (16.9% versus −51.3% for Onconetix).
YD Bio keeps more of each dollar of sales as profit, with a net margin of −1393% compared with −1579% at Onconetix.
YD Bio scores higher on the StockData Score (5 against 3 for Onconetix), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | ONCO | YDES |
|---|---|---|
| Size and price | ||
| Market cap | $12.7M | – |
| Share price | $3.21 | $4.88 |
| Change, 1 year | −99.8% | −44.8% |
| Change, 5 years | −100.0% | −52.0% |
| Beta (5Y) | 4.73 | 0.10 |
| Employees | 12 | 13 |
| StockData Score | ||
| Total score | 3 | 5 (better) |
| Valuation score | 1 (better) | 0 |
| Growth score | 1 (better) | 0 |
| Performance score | 0 | 0 |
| Health score | 1 | 5 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 19.6× | – |
| P/B | 0.9× | – |
| Growth | ||
| Revenue growth (TTM) | −51.3% | 16.9% (better) |
| Profitability | ||
| Gross margin | 80.4% (better) | 28.1% |
| Operating margin | −2525% | −883% (better) |
| Net margin | −1579% | −1393% (better) |
| FCF margin | – | −1347% |
| Return on equity | −105% (better) | −174% |
| Return on invested capital | −196% | −130% (better) |
| Financial health | ||
| Debt / equity | – | 0.00 |
| Interest coverage | −52.4× | – |
| Current ratio | 2.21 | 5.23 (better) |
| Altman Z-score | −12.19 | – |
| Piotroski F-score | 6 (better) | 2 |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | – |
| Ownership | ||
| Held by institutions | 1.7% | – |
| Held by insiders | 40.3% | 92.8% |
| Insider net buying, 12 months | $8.4K | $129K (better) |
| Short interest, % of float | 40.6% | – |
Go deeper
- ONCO stock overview
- ONCO income statement
- ONCO valuation and score
- YDES stock overview
- YDES income statement
- YDES valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.